Target intelligence / Profile preview

Influenza B nucleoprotein (NP (for nucleoprotein))

Target
NP (for nucleoprotein)
Molecular classification
Viral nucleoprotein, Ribonucleoprotein component, Other
01

Overview

Influenza B nucleoprotein is the primary structural and functional component of the viral ribonucleoprotein (RNP) complex in Influenza B viruses, essential for viral RNA encapsidation and for the regulation of both transcription and replication of the viral genome[1][2][4]. It forms homo-oligomers through tail-loop insertions, binds viral RNA in an electropositive groove, and shuttles the RNP complex into the host nucleus via a nuclear localization signal located in its extended N-terminal region[1][2][3]. The nucleoprotein is highly conserved within influenza B viruses but possesses an N-terminal extension distinguishing it from influenza A nucleoprotein, and this extension is critical for viral viability and nuclear import[2][3]. Because of its central role in viral replication, it is an attractive target for antiviral drug development and a reliable diagnostic marker for infection[2].

Other names
Influenza B virus nucleoproteinInfluenza B NPBNP
02

Mechanism of action

Inhibition of nucleoprotein blocks viral RNA encapsidation, thereby impairing genome replication and transcription[1][2] - Disruption of nuclear import prevents replication complex assembly[3]

03

Biological functions

Viral genome encapsidationRegulation of viral transcriptionRegulation of viral RNA replicationNuclear import of viral ribonucleoprotein complexOligomerization to form viral RNP architecture
04

Disease associations

Infection (specifically, Influenza B virus infection)
05

Safety considerations

Specific targeting of viral nucleoprotein is generally considered to have a favorable safety profile due to lack of human homologs; potential concerns include off-target effects if host protein interactions (e.g., importins) are disrupted[3]
06

Interacting drugs

None approved or established as directly binding; potential for future small molecule antivirals targeting RNA binding or oligomerization sites[1][2][4]

1 more in the full profile.

07

Biomarkers

Presence of Influenza B nucleoprotein in patient samples used as a diagnostic marker for active infection[2]

Beyond the preview

Go deeper on Influenza B nucleoprotein (NP (for nucleoprotein)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza B nucleoprotein (NP (for nucleoprotein)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call